New Market Study, "Lymphoblastic Lymphoma - Pipeline Review, H2 2012", Has Been Published
Global Markets Direct's, 'Lymphoblastic Lymphoma - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Lymphoblastic Lymphoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Lymphoblastic Lymphoma. Lymphoblastic Lymphoma - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations...
View full press release